However, resveratrol supplementation was associated with a significant reduction in liver ALT, inflammatory cytokines, NF-κβ activity, serum cytokeratin 18, and grade of hepatic steatosis, compared to placebo-supplemented group. Here, GPT is linked to Hepatic steatosis.